Factsheets

Technology development

• Non gene drive genetically modified male bias mosquitoes
• The Science: What is gene drive?
• Resistance to gene drive
• Malaria: Where do gene drive technologies fit in?
• Doublesex Construct

Development pathway

• Results of the small-scale release of non gene drive genetically modified sterile male mosquitoes in Burkina Faso
• Evaluating our gene drive technology
• Funding our research
• Target Malaria’s step-by-step development pathway
• Intellectual property

Malaria and its vectors

• Malaria vs Dengue: what are the similarities and differences
• The competitors of Anopheles gambiae s.l.
• The predators of Anopheles gambiae
• Anopheles gambiae species complex and gene transfer
• Anopheles gambiae s.l.: morphology, life cycle, ecology
• An ecological observatory

Risk assessment

• Environmental Risk Assessment (ERA)
• Safety measures for work on genetically modified mosquitoes in containment
• What is risk assessment
• Potential human & environmental impacts of gene drive mosquito releases on other mosquito species

Stakeholder engagement

• Our community agreement model for the release of non gene drive genetically modified fertile mosquitoes
• Stakeholder engagement rationale and approach
• How do communities make informed decisions about our work?
• Target Malaria’s approach to linguistics
• Grievance management mechanisms

Regulatory Affairs

• ESIA Factsheet 3: Key potential impact assessment areas for genetically modified mosquito research
• ESIA Factsheet 2: The Environmental, Social, and Health Impact Assessment (ESHIA) process
• ESIA Factsheet 1: Understanding Environmental, Social, and Health Impact Assessment (ESHIA)
• International policy framework for genetically modified mosquitoes

Insectaries & field entomology

• Target Malaria’s insectaries
• Mosquito collection methods
• Field entomology and laboratory work

Brochures

• Target Malaria: Italy (Italian)
• Target Malaria: Italy
• Target Malaria Brochure (Italian)
• Target Malaria Brochure
• Target Malaria: Ghana
• Target Malaria: Burkina Faso
• Target Malaria: Uganda

Statements

• Not-for-profit statement
• About Biocentis